ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,463.54
      0.08%
      US Tech 100
      18,480.00
      -0.21%
      Dow Jones
      40,539.93
      -0.12%
      Brent Oil
      78.605
      -0.68%
      Bitcoin
      66,659.69
      -0.25%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Sage Therapeutics Inc (SAGE) Quote

      Sage Therapeutics Inc

      Sage Therapeutics Inc (SAGE)

      Sage Potash Corp
      10.81
      -0.18
      (-1.64%)
      Closed July 30 4:00PM
      Delayed by 15 minutes
      10.81
      0.00
      (0.00%)
      After Hours: 6:16PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      10.81
      Bid
      10.13
      Ask
      12.50
      Volume
      820,366
      10.66 Day's Range 11.25
      9.73 52 Week Range 37.165
      Market Cap
      650.568M
      Previous Close
      10.99
      Open
      10.96
      Last Trade
      6
      @
      11
      Last Trade Time
      Financial Volume
      $ 8,914,906
      VWAP
      10.867
      Average Volume (3m)
      1,203,339
      Shares Outstanding
      60,182,031
      Dividend Yield
      -
      PE Ratio
      -1.20
      Earnings Per Share (EPS)
      -9
      Revenue
      86.46M
      Net Profit
      -541.49M

      About Sage Therapeutics Inc

      Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical tri... Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company's lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson's disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.sagerx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Sage Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker SAGE. The last closing price for Sage Therapeutics was $10.99. Over the last year, Sage Therapeutics shares have traded in a share price range of $ 9.73 to $ 37.165.

      Sage Therapeutics currently has 60,182,031 shares outstanding. The market capitalization of Sage Therapeutics is $661.40 million. Sage Therapeutics has a price to earnings ratio (PE ratio) of -1.20.

      SAGE Latest News

      More News

      FeaturedCannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA

      18 hours ago

      Yen Rises Against Majors

      (RTTNews) - The Japanese yen strengthened against other major currencies in the Asian session on Monday. The yen rose to 4-day highs of 166.28 against the euro, 153.03 against the U.S. dollar...

      July 28 2024
      RTTF2

      Yen Rises To 4-day High Of 90.22 Against NZ Dollar

      July 28 2024
      RTTF2

      Yen Ticks Up To 100.41 Against Australian Dollar

      July 28 2024
      RTTF2

      Yen Edges Up To 197.20 Against Pound

      July 28 2024
      RTTF2

      Yen Climbs To 4-day High Of 173.48 Against Swiss Franc

      July 28 2024
      RTTF2

      Yen Advances To 4-day High Of 153.03 Against U.S. Dollar

      July 28 2024
      RTTF2

      Yen Rises To 4-day High Of 166.34 Against Euro

      July 28 2024
      RTTF2

      Eurozone Inflation Expectations Remain Unchanged

      (RTTNews) - Eurozone consumers' inflation expectations remained stable in July, the latest consumer expectations survey published by the European Central Bank showed on Friday. Inflation...

      July 26 2024
      RTTF2

      Yen Falls Against Majors

      (RTTNews) - The Japanese yen weakened against other major currencies in the European session on Friday. The yen fell to a 2-day low of 154.45 against the U.S. dollar, from an early high of...

      July 26 2024
      RTTF2
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-1.58-12.752219531912.3913.479.73139634211.17655526CS
      4-0.05-0.46040515653810.8613.479.7393250411.38690878CS
      12-3.19-22.78571428571414.30899.73120333911.35691805CS
      26-15.36-58.69316010726.1727.399.73111728615.300597CS
      52-24.3-69.211050982635.1137.1659.73120402618.4151418CS
      156-34.16-75.961752279344.9759.999.7379719129.41943727CS
      260-154.81-93.473010506165.62174.739.7379432143.80708329CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TWOU2U Inc
      $ 2.70
      (116.00%)
      		139.18M
      LIPOLipella Pharmaceuticals Inc
      $ 0.8576
      (112.22%)
      		194.69M
      NIPGNIP Group Inc
       16.50
      (82.93%)
      		7.04M
      TIVCTivic Health Systems Inc
      $ 0.7049
      (55.95%)
      		106.15M
      ISPOInspirato Inc
      $ 5.15
      (47.99%)
      		6.24M
      CGTXCognition Therapeutics Inc
      $ 1.32
      (-44.30%)
      		26.32M
      GRIGRI Bio Inc
      $ 0.8334
      (-33.86%)
      		1.14M
      CEROCERo Therapeutics Holdings Inc
      $ 0.1817
      (-29.02%)
      		8.28M
      PRSTPresto Technologies Inc
      $ 0.0499
      (-26.51%)
      		29.32M
      TGLTreasure Global Inc
      $ 1.40
      (-24.32%)
      		80.79k
      NVDANVIDIA Corporation
      $ 111.59
      (-1.30%)
      		248.03M
      LIPOLipella Pharmaceuticals Inc
      $ 0.8576
      (112.22%)
      		194.69M
      SQQQProShares UltraPro Short QQQ
      $ 9.05
      (-0.55%)
      		152.03M
      TWOU2U Inc
      $ 2.70
      (116.00%)
      		139.18M
      TSLATesla Inc
      $ 232.10
      (5.60%)
      		129.2M

      SAGE Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      SAGE over $10
      👍️0
      everton44 everton44 12 months ago
      SAGE going to 36 dollars, every article and financial companies downgrading SAGE yet it goes up big. HAHAHA
      👍️0
      gail gail 12 months ago
      i dont know anything about…

      …

      shorting. i am a simpleton, lol, i just trade like a normal trader.

      not in this one, but made a bundle on my last few trades, including ttoo today. weeee!!
      👍️0
      everton44 everton44 12 months ago
      we are all short selling the piss out of this now, come on board
      👍️0
      gail gail 12 months ago
      so, they got approved yet…

      ..

      it dropped huge today? im not in it but watching.
      👍️0
      AGORDON AGORDON 12 months ago
      FDA approved Zuranolone for PPD. CRL for Major Depressive.
      👍️0
      AGORDON AGORDON 12 months ago
      The FDA is still considering whether to approve zuranolone for clinical depression in addition to postpartum depression, but did not issue a decision on that indication.
      👍️0
      budgetthis budgetthis 2 years ago
      I was gonna burn some SAGE today, in a therapeutic manner, like they do on Yellowstone to ward off evil spirits.

      But no need……elevators going up today……lol.

      $$ SAGE $$
      👍️0
      CjMitts CjMitts 3 years ago
      Called the pump, How'd I know, garbby 10q report, RSI divergence. will be loading this at the bottom though with the money I make from this short, the potential of this companies pipeline is enormous.
      👍️0
      CjMitts CjMitts 3 years ago
      Boom
      👍️0
      CjMitts CjMitts 3 years ago
      Dont be fooled by the pump. Will be loading between 34-26. Surprised there's no talk on this page regarding the potential of this companies pipeline.
      👍️0
      thumper1 thumper1 4 years ago
      im out high 68.eom
      👍️0
      thumper1 thumper1 4 years ago
      bought 67.11. we will see
      👍️0
      NYCPuglet NYCPuglet 4 years ago
      Sold at 77. Thank god. Lol.
      👍️0
      NYCPuglet NYCPuglet 5 years ago
      In 1000 @ at 73. Easy profit flipper here. Very big whales behind this company.
      👍️0
      Daysinn4610 Daysinn4610 5 years ago
      Ceo cfo cso all buying shares https://www.gurufocus.com/news/999044/sage-therapeutics-inc-sage-president--ceo-jeffrey-m-jonas-bought-481500-of-shares
      👍️0
      Daysinn4610 Daysinn4610 5 years ago
      Some sage news https://www.streetinsider.com/dr/news.php?id=16261148
      👍️0
      keekee keekee 5 years ago
      Lol....brig6and early. Crossing $80 today? The $125 may actually happen by the end if the month? We will see.
      👍️0
      keekee keekee 5 years ago
      Seen this...though it is going to be just a few days apart. Congrats to BULLS....and I sure hope those that jumped in to short because I highlighted the stock GO BANKRUPT!!!
      👍️0
      keekee keekee 5 years ago
      $74 now. Everyone that shorted past week is now in red. And it will get even more painful going forward. Sorry, losers!
      👍️0
      keekee keekee 5 years ago
      $3 to $4 a day is fine for now. In a week or so we wi6see doing more than that number as we race back towards $125. When I saw BUY...and some.fools sell, all I think of is, Who the hell is their father!!!! Who do they get information from...David Einhorn or who? He just did 34% loss last year and is on track to be smothered again with the TSLA outperformance. We are headed up....Intelsat, SAGE, ASLN, FRAN, And a host of others.
      👍️0
      keekee keekee 5 years ago
      We're headed to $80 very likely today. It's a one way train here m.j till.$100.
      👍️0
      Biobonic Biobonic 5 years ago
      Post-hoc analysis revealed that in the MOUNTAIN Study, approximately 9% of patients in the SAGE-217 30 mg group had no measurable drug concentration, consistent with non-compliance in taking SAGE-217

      In the 30mg group, 192 received the medication at the onset of the trial.

      9% would approximate: 17 participants.

      The trial had 28 participants withdraw by day 42. (14%) a significant number, especially since there was a good measure of efficacy.



      👍️0
      RJ Trotts RJ Trotts 5 years ago
      I got out with 4.50 per share profit, we are both happy, enjoy your weekend. Hoping to find more winners next week.
      👍️0
      Nebuchadnezzar Nebuchadnezzar 5 years ago
      Caught this falling knife yesterday, out up $6.45 profit
      👍️0
      keekee keekee 5 years ago
      Watch when this stock went down from $68 yestersay. That was when I intentionally posted that I loaded. They came.and brought the it down. I reloaded. And they sre still here. Ditto for PTGX, 1, PRTY, AIHS, ASLN, AFH, SLDB, AFI, CBAY, ATIS. and a couple more. The have shorted most of these floats over 100% but still.manages tonhang on because folks have no idea that these stocks will fly double or triple. But check those out and good luck. They are mostly DOUBLERS in a month or two.
      👍️0
      keekee keekee 5 years ago
      There are folks that short anything I buy. They are the idiots holding this down. CV lick on my name to see other stocks we play opposite. They have money but no brain. Investor money. They will shi ort anything I posted that I bought under any circumstance. They are the knes here. Ignote the selling and load. This will fly!!!
      👍️0
      T695 T695 5 years ago
      I think we at resistance in the $66 are. The entire market will be over bought in a minute and this will sell off hard
      👍️0
      keekee keekee 5 years ago
      Minimum close today will be $70. I will take that..from $54 and lower entry yesterday. This one is as easy...easy. will likely be trending toward $100 by month end
      👍️0
      T695 T695 5 years ago
      Looks like my first outlook was the right one
      👍️0
      VictorMasonIsRight VictorMasonIsRight 5 years ago
      SAGE test compromised by 9 non compliant patients?
      Otherwise would have met all benchmarks?

      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=152647122
      👍️0
      RJ Trotts RJ Trotts 5 years ago
      up in pre-market right now, here's to hoping it bounces nicely
      👍️0
      T695 T695 5 years ago
      On second thoughts, might me another 20% or so haircut today after all the downgrades
      👍️0
      T695 T695 5 years ago
      It’s way over sold, but still could fall to 50ish
      👍️0
      T695 T695 5 years ago
      I’m thinking we get a bounce from here to $66-67ish, when if it hits there it may either run back to low 70’s or pull back to 50’s then run to $70’s.... either way I see lows 50’s and lows 70’s as short term bottom and top
      👍️0
      RJ Trotts RJ Trotts 5 years ago
      May add some here after hours, and see if it will bounce tomorrow. Best to all here. Hoping it is oversold!
      👍️0
      keekee keekee 5 years ago
      Unfortunately, I brought them over..I mean the heavy sellers. These guys are blind in their rabid quest to trade against me. But I create losses for them. That is my mission now. We will see $100. The clueless sellers know it too!
      👍️0
      keekee keekee 5 years ago
      Will cross $80 tom8. Must $100 by next week. The fools selling are misguided
      👍️0
      T695 T695 5 years ago
      Might see by EOD
      👍️0
      keekee keekee 5 years ago
      This thing may actually return to $1.25 by year end. That would be over 200% for.me. lol. In at $54 and lower..pre.
      👍️0
      keekee keekee 5 years ago
      Loaded premkt at $53. Must get $100. Drug did not fail if you factor in the 9 candidates that did not take it. $100..let's go
      👍️0
      T695 T695 5 years ago
      Make take a nibble at $50
      👍️0
      altruism altruism 5 years ago
      4 according to 1 news source I saw
      👍️0
      Awl416 Awl416 5 years ago
      How many billions that she’s off the market cap - wow
      👍️0
      NYCPuglet NYCPuglet 5 years ago
      Such an easy predictable stock.
      👍️0
      cvm101 cvm101 5 years ago
      So this Leerink Swann call of 1/7 is looking pretty idiotic now as stock crosses $144.00
      Earlier they had downgraded and lowered target price to $80.00

      Sage Therapeutics stock price target raised to $90 from $80 at Leerink
      👍️0
      NYCPuglet NYCPuglet 6 years ago
      Once again it drops. Gotta love this flipper.
      👍️0
      NYCPuglet NYCPuglet 6 years ago
      Wish I had funds last week to throw in. I sensed a big pop was coming.
      👍️0
      cvm101 cvm101 6 years ago
      Well it has been - but with the approval to market the new drug its less a speculation and more an investable company. Longer term its worth $200. Most analyst target prices are in that area.
      👍️0
      NYCPuglet NYCPuglet 6 years ago
      Yep. This is an insane flipper stock.
      👍️0

      Your Recent History

      NASDAQ
      SAGE
      Sage Therapeutics
      BIT
      P1LBK5
      BNP Paribas Issuance
      Delayed Upgrade Clock